SLX4 and breast cancer: Both genes have been investigated regarding BC susceptibility, with some common ERCC1 variants being identified as risk alleles in Chinese population (Yang et al., 2013) and rare truncating and possibly damaging variants in SLX4 being described in some high risk HBOC patients (Bakker et al., 2013; Shah et al., 2013).